← Back to headlines
FDA Accepts Roche Application for Lupus Treatment Gazyva/Gazyvaro
The U.S. Food and Drug Administration has accepted Roche's application for its drug Gazyva/Gazyvaro, intended for the treatment of common lupus.
21 Apr, 05:22 — 21 Apr, 05:22
Sources
Showing 1 of 1 sources
Related Stories
South Korea, US and Japan to Hold Freedom Edge Drills in Early September
19m ago
Trump Orders Lake Ontario Renamed 'Lake America' Amid Canadian Backlash
26m ago
Rescuers Race to Find Survivors in Nepal and Tibet Floods
33m ago
Police Disperse Mob That Burned Migrant Camp in Spanish Enclave of Ceuta
50m ago